| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Research &Development | SVP, Development | SVP, Development
1 company
Graham Richard A serves as a SVP, Research &Development at TBPH. Across recent SEC filings that breaks down to 0 buys and 14 sells. Those positions are worth an estimated $2.8M at current prices.
Historically, Graham Richard A's trades have earned a strong insider score of 71/100 across 13 rated trades. Over a 12-month horizon, 92.3% of those trades were profitable, with an average 12-month return of +9.9%.
The biggest single holding is TBPH (~$2.8M) as SVP, Research &Development. The recent filings there lean toward selling, a net 53,279 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,084 | $10.73 | $22,361.32 | -0.7% | -7.0% | -1.4% | |
| Aug 16, 2022 | TBPH Theravance Biopharma, Inc. | SVP, Development | Sell | 4,906 | $9.71 | $47,639.71 | -1.3% | +14.9% | -0.8% | |
| Aug 9, 2022 | TBPH Theravance Biopharma, Inc. | SVP, Development | Sell | 15,086 | $8.79 | $132,605.94 | -3.9% | +11.7% | +13.3% | |
| Dec 14, 2020 | TBPH Theravance Biopharma, Inc. | SVP, Development | Sell | 7,500 | $19.47 | $146,058.00 | -5.7% | - | - |